Research Article - (2015) Volume 5, Issue 2

Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE

Arianna Scuteri1,4*, Elisabetta Donzelli1,4, Roberta Rigolio1,4, Elisa Ballarini1,4, Marianna Monfrini1,2,4, Luca Crippa3, Alessia Chiorazzi1,4, Valentina Carozzi1,4, Cristina Meregalli1,4, Annalisa Canta1,4, Norberto Oggioni1,4, Giovanni Tredici1,4 and Guido Cavaletti1,4
1Experimental Neurology Unit, Department of Surgery and Translational Medicine, University of Milano-Bicocca, Monza, Italy, E-mail: arianna.scuteri@unimib.it
2Neuroscience Program, University of Milano-Bicocca, Monza, Italy, E-mail: arianna.scuteri@unimib.it
3Istovet, Laboratory of histopathology and Veterinary Services for Scientific Research, Besana Brianza (MB), Italy, E-mail: arianna.scuteri@unimib.it
4NeuroMI - Milan Center for Neuroscience, Italy, E-mail: arianna.scuteri@unimib.it
*Corresponding Author: